Free Trial

PTC Therapeutics (PTCT) SEC Filings & 10K Form

PTC Therapeutics logo
$39.23 -3.15 (-7.43%)
(As of 11/15/2024 ET)

Recent PTC Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/18/2024
9:57 AM
PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/18/2024
5:35 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:45 PM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Filed by)
Form SC 13D/A
08/08/2024
3:35 PM
PTC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
4:20 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
2:14 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
6:00 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:55 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
4:20 PM
PTC Therapeutics (Issuer)
ZELDIS JEROME B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
9:12 AM
PTC Therapeutics (Subject)
ZELDIS JEROME B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
6:20 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:20 PM
PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
4:20 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
2:30 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:24 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:13 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
4:16 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
2:58 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:36 PM
PTC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:20 PM
Bell William F. Jr. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:25 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:11 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:16 PM
Okey Stephanie (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G
02/14/2024
6:13 AM
PTC Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/08/2024
9:17 AM
PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/30/2024
2:17 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:25 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
3:30 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t
01/24/2024
12:11 PM
PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
3:11 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
3:06 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:08 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:09 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:10 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:11 PM
PTC Therapeutics (Issuer)
Utter Christine Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
FMR LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/09/2024
4:46 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:35 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:29 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:30 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:33 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:16 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:17 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:23 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:47 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/08/2024
3:37 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:46 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:29 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:34 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:46 AM
PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:27 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
4:12 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:38 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTCT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners